img

Global Precision Oncology Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Precision Oncology Market Insights, Forecast to 2034

Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.
Market Analysis and InsightsGlobal Precision Oncology Market
Global Precision Oncology market is expected to reach to US$ 105170 million in 2023, with a positive growth of %, compared with US$ 95500 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Precision Oncology industry is evaluated to reach US$ 184490 million in 2033. The CAGR will be 9.8% during 2023 to 2033.
Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.
Report Covers
This report presents an overview of global Precision Oncology market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Precision Oncology market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology, Inc.
Thermo Fisher Scientific Inc.
Variantyx, Inc.
Segment by Type
Diagnostics
Therapeutics

Segment by Application


Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Precision Oncology introduction, etc. Precision Oncology Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Precision Oncology
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Oncology Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Precision Oncology Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Diagnostic Laboratories
1.3.4 Healthcare Data Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Oncology Market Perspective (2018-2033)
2.2 Global Precision Oncology Growth Trends by Region
2.2.1 Precision Oncology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Precision Oncology Historic Market Size by Region (2018-2023)
2.2.3 Precision Oncology Forecasted Market Size by Region (2024-2033)
2.3 Precision Oncology Market Dynamics
2.3.1 Precision Oncology Industry Trends
2.3.2 Precision Oncology Market Drivers
2.3.3 Precision Oncology Market Challenges
2.3.4 Precision Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Precision Oncology by Players
3.1.1 Global Precision Oncology Revenue by Players (2018-2023)
3.1.2 Global Precision Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Precision Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Precision Oncology, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Precision Oncology Market Concentration Ratio
3.4.1 Global Precision Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Oncology Revenue in 2022
3.5 Global Key Players of Precision Oncology Head office and Area Served
3.6 Global Key Players of Precision Oncology, Product and Application
3.7 Global Key Players of Precision Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Oncology Breakdown Data by Type
4.1 Global Precision Oncology Historic Market Size by Type (2018-2023)
4.2 Global Precision Oncology Forecasted Market Size by Type (2024-2033)
5 Precision Oncology Breakdown Data by Application
5.1 Global Precision Oncology Historic Market Size by Application (2018-2023)
5.2 Global Precision Oncology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Precision Oncology Market Size (2018-2033)
6.2 North America Precision Oncology Market Size by Type
6.2.1 North America Precision Oncology Market Size by Type (2018-2023)
6.2.2 North America Precision Oncology Market Size by Type (2024-2033)
6.2.3 North America Precision Oncology Market Share by Type (2018-2033)
6.3 North America Precision Oncology Market Size by Application
6.3.1 North America Precision Oncology Market Size by Application (2018-2023)
6.3.2 North America Precision Oncology Market Size by Application (2024-2033)
6.3.3 North America Precision Oncology Market Share by Application (2018-2033)
6.4 North America Precision Oncology Market Size by Country
6.4.1 North America Precision Oncology Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Precision Oncology Market Size by Country (2018-2023)
6.4.3 North America Precision Oncology Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Precision Oncology Market Size (2018-2033)
7.2 Europe Precision Oncology Market Size by Type
7.2.1 Europe Precision Oncology Market Size by Type (2018-2023)
7.2.2 Europe Precision Oncology Market Size by Type (2024-2033)
7.2.3 Europe Precision Oncology Market Share by Type (2018-2033)
7.3 Europe Precision Oncology Market Size by Application
7.3.1 Europe Precision Oncology Market Size by Application (2018-2023)
7.3.2 Europe Precision Oncology Market Size by Application (2024-2033)
7.3.3 Europe Precision Oncology Market Share by Application (2018-2033)
7.4 Europe Precision Oncology Market Size by Country
7.4.1 Europe Precision Oncology Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Precision Oncology Market Size by Country (2018-2023)
7.4.3 Europe Precision Oncology Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Precision Oncology Market Size (2018-2033)
8.2 China Precision Oncology Market Size by Type
8.2.1 China Precision Oncology Market Size by Type (2018-2023)
8.2.2 China Precision Oncology Market Size by Type (2024-2033)
8.2.3 China Precision Oncology Market Share by Type (2018-2033)
8.3 China Precision Oncology Market Size by Application
8.3.1 China Precision Oncology Market Size by Application (2018-2023)
8.3.2 China Precision Oncology Market Size by Application (2024-2033)
8.3.3 China Precision Oncology Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Precision Oncology Market Size (2018-2033)
9.2 Asia Precision Oncology Market Size by Type
9.2.1 Asia Precision Oncology Market Size by Type (2018-2023)
9.2.2 Asia Precision Oncology Market Size by Type (2024-2033)
9.2.3 Asia Precision Oncology Market Share by Type (2018-2033)
9.3 Asia Precision Oncology Market Size by Application
9.3.1 Asia Precision Oncology Market Size by Application (2018-2023)
9.3.2 Asia Precision Oncology Market Size by Application (2024-2033)
9.3.3 Asia Precision Oncology Market Share by Application (2018-2033)
9.4 Asia Precision Oncology Market Size by Region
9.4.1 Asia Precision Oncology Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Precision Oncology Market Size by Region (2018-2023)
9.4.3 Asia Precision Oncology Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Precision Oncology Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Precision Oncology Market Size by Type
10.2.1 Middle East, Africa, and Latin America Precision Oncology Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Precision Oncology Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Precision Oncology Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Precision Oncology Market Size by Application
10.3.1 Middle East, Africa, and Latin America Precision Oncology Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Precision Oncology Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Precision Oncology Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Precision Oncology Market Size by Country
10.4.1 Middle East, Africa, and Latin America Precision Oncology Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Precision Oncology Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Precision Oncology Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Acrivon Therapeutics
11.1.1 Acrivon Therapeutics Company Details
11.1.2 Acrivon Therapeutics Business Overview
11.1.3 Acrivon Therapeutics Precision Oncology Introduction
11.1.4 Acrivon Therapeutics Revenue in Precision Oncology Business (2018-2023)
11.1.5 Acrivon Therapeutics Recent Developments
11.2 Bio-Serv
11.2.1 Bio-Serv Company Details
11.2.2 Bio-Serv Business Overview
11.2.3 Bio-Serv Precision Oncology Introduction
11.2.4 Bio-Serv Revenue in Precision Oncology Business (2018-2023)
11.2.5 Bio-Serv Recent Developments
11.3 Exact Sciences Corporation
11.3.1 Exact Sciences Corporation Company Details
11.3.2 Exact Sciences Corporation Business Overview
11.3.3 Exact Sciences Corporation Precision Oncology Introduction
11.3.4 Exact Sciences Corporation Revenue in Precision Oncology Business (2018-2023)
11.3.5 Exact Sciences Corporation Recent Developments
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Details
11.4.2 Illumina, Inc. Business Overview
11.4.3 Illumina, Inc. Precision Oncology Introduction
11.4.4 Illumina, Inc. Revenue in Precision Oncology Business (2018-2023)
11.4.5 Illumina, Inc. Recent Developments
11.5 Invitae Corporation
11.5.1 Invitae Corporation Company Details
11.5.2 Invitae Corporation Business Overview
11.5.3 Invitae Corporation Precision Oncology Introduction
11.5.4 Invitae Corporation Revenue in Precision Oncology Business (2018-2023)
11.5.5 Invitae Corporation Recent Developments
11.6 Laboratory Corporation of America
11.6.1 Laboratory Corporation of America Company Details
11.6.2 Laboratory Corporation of America Business Overview
11.6.3 Laboratory Corporation of America Precision Oncology Introduction
11.6.4 Laboratory Corporation of America Revenue in Precision Oncology Business (2018-2023)
11.6.5 Laboratory Corporation of America Recent Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Precision Oncology Introduction
11.7.4 QIAGEN Revenue in Precision Oncology Business (2018-2023)
11.7.5 QIAGEN Recent Developments
11.8 Rain Oncology
11.8.1 Rain Oncology Company Details
11.8.2 Rain Oncology Business Overview
11.8.3 Rain Oncology Precision Oncology Introduction
11.8.4 Rain Oncology Revenue in Precision Oncology Business (2018-2023)
11.8.5 Rain Oncology Recent Developments
11.9 Relay Therapeutics
11.9.1 Relay Therapeutics Company Details
11.9.2 Relay Therapeutics Business Overview
11.9.3 Relay Therapeutics Precision Oncology Introduction
11.9.4 Relay Therapeutics Revenue in Precision Oncology Business (2018-2023)
11.9.5 Relay Therapeutics Recent Developments
11.10 Strata Oncology, Inc.
11.10.1 Strata Oncology, Inc. Company Details
11.10.2 Strata Oncology, Inc. Business Overview
11.10.3 Strata Oncology, Inc. Precision Oncology Introduction
11.10.4 Strata Oncology, Inc. Revenue in Precision Oncology Business (2018-2023)
11.10.5 Strata Oncology, Inc. Recent Developments
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Details
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Precision Oncology Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2018-2023)
11.11.5 Thermo Fisher Scientific Inc. Recent Developments
11.12 Variantyx, Inc.
11.12.1 Variantyx, Inc. Company Details
11.12.2 Variantyx, Inc. Business Overview
11.12.3 Variantyx, Inc. Precision Oncology Introduction
11.12.4 Variantyx, Inc. Revenue in Precision Oncology Business (2018-2023)
11.12.5 Variantyx, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Precision Oncology Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Precision Oncology Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Precision Oncology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Precision Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Precision Oncology Market Share by Region (2018-2023)
Table 8. Global Precision Oncology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Precision Oncology Market Share by Region (2024-2033)
Table 10. Precision Oncology Market Trends
Table 11. Precision Oncology Market Drivers
Table 12. Precision Oncology Market Challenges
Table 13. Precision Oncology Market Restraints
Table 14. Global Precision Oncology Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Precision Oncology Revenue Share by Players (2018-2023)
Table 16. Global Top Precision Oncology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2022)
Table 17. Global Precision Oncology Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Precision Oncology Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Precision Oncology, Headquarters and Area Served
Table 20. Global Key Players of Precision Oncology, Product and Application
Table 21. Global Key Players of Precision Oncology, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Precision Oncology Revenue Market Share by Type (2018-2023)
Table 25. Global Precision Oncology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Precision Oncology Revenue Market Share by Type (2024-2033)
Table 27. Global Precision Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Precision Oncology Revenue Share by Application (2018-2023)
Table 29. Global Precision Oncology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Precision Oncology Revenue Share by Application (2024-2033)
Table 31. North America Precision Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Precision Oncology Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Precision Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Precision Oncology Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Precision Oncology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Precision Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Precision Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Precision Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Precision Oncology Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Precision Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Precision Oncology Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Precision Oncology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Precision Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Precision Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Precision Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Precision Oncology Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Precision Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Precision Oncology Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Precision Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Precision Oncology Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Precision Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Precision Oncology Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Precision Oncology Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Precision Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Precision Oncology Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Precision Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Precision Oncology Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Precision Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Precision Oncology Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Precision Oncology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Precision Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Precision Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 63. Acrivon Therapeutics Company Details
Table 64. Acrivon Therapeutics Business Overview
Table 65. Acrivon Therapeutics Precision Oncology Product
Table 66. Acrivon Therapeutics Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 67. Acrivon Therapeutics Recent Developments
Table 68. Bio-Serv Company Details
Table 69. Bio-Serv Business Overview
Table 70. Bio-Serv Precision Oncology Product
Table 71. Bio-Serv Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 72. Bio-Serv Recent Developments
Table 73. Exact Sciences Corporation Company Details
Table 74. Exact Sciences Corporation Business Overview
Table 75. Exact Sciences Corporation Precision Oncology Product
Table 76. Exact Sciences Corporation Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 77. Exact Sciences Corporation Recent Developments
Table 78. Illumina, Inc. Company Details
Table 79. Illumina, Inc. Business Overview
Table 80. Illumina, Inc. Precision Oncology Product
Table 81. Illumina, Inc. Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 82. Illumina, Inc. Recent Developments
Table 83. Invitae Corporation Company Details
Table 84. Invitae Corporation Business Overview
Table 85. Invitae Corporation Precision Oncology Product
Table 86. Invitae Corporation Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 87. Invitae Corporation Recent Developments
Table 88. Laboratory Corporation of America Company Details
Table 89. Laboratory Corporation of America Business Overview
Table 90. Laboratory Corporation of America Precision Oncology Product
Table 91. Laboratory Corporation of America Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 92. Laboratory Corporation of America Recent Developments
Table 93. QIAGEN Company Details
Table 94. QIAGEN Business Overview
Table 95. QIAGEN Precision Oncology Product
Table 96. QIAGEN Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 97. QIAGEN Recent Developments
Table 98. Rain Oncology Company Details
Table 99. Rain Oncology Business Overview
Table 100. Rain Oncology Precision Oncology Product
Table 101. Rain Oncology Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 102. Rain Oncology Recent Developments
Table 103. Relay Therapeutics Company Details
Table 104. Relay Therapeutics Business Overview
Table 105. Relay Therapeutics Precision Oncology Product
Table 106. Relay Therapeutics Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 107. Relay Therapeutics Recent Developments
Table 108. Strata Oncology, Inc. Company Details
Table 109. Strata Oncology, Inc. Business Overview
Table 110. Strata Oncology, Inc. Precision Oncology Product
Table 111. Strata Oncology, Inc. Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 112. Strata Oncology, Inc. Recent Developments
Table 113. Thermo Fisher Scientific Inc. Company Details
Table 114. Thermo Fisher Scientific Inc. Business Overview
Table 115. Thermo Fisher Scientific Inc. Precision Oncology Product
Table 116. Thermo Fisher Scientific Inc. Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 117. Thermo Fisher Scientific Inc. Recent Developments
Table 118. Variantyx, Inc. Company Details
Table 119. Variantyx, Inc. Business Overview
Table 120. Variantyx, Inc. Precision Oncology Product
Table 121. Variantyx, Inc. Revenue in Precision Oncology Business (2018-2023) & (US$ Million)
Table 122. Variantyx, Inc. Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Oncology Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Precision Oncology Market Share by Type: 2022 VS 2033
Figure 3. Diagnostics Features
Figure 4. Therapeutics Features
Figure 5. Global Precision Oncology Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Precision Oncology Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical & Biotechnology Companies Case Studies
Figure 8. Hospitals & Diagnostic Laboratories Case Studies
Figure 9. Healthcare Data Companies Case Studies
Figure 10. Precision Oncology Report Years Considered
Figure 11. Global Precision Oncology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Precision Oncology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Precision Oncology Market Share by Region: 2022 VS 2033
Figure 14. Global Precision Oncology Market Share by Players in 2022
Figure 15. Global Top Precision Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Oncology as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Precision Oncology Revenue in 2022
Figure 17. North America Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Precision Oncology Market Share by Type (2018-2033)
Figure 19. North America Precision Oncology Market Share by Application (2018-2033)
Figure 20. North America Precision Oncology Market Share by Country (2018-2033)
Figure 21. United States Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Precision Oncology Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Precision Oncology Market Share by Type (2018-2033)
Figure 25. Europe Precision Oncology Market Share by Application (2018-2033)
Figure 26. Europe Precision Oncology Market Share by Country (2018-2033)
Figure 27. Germany Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Precision Oncology Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Precision Oncology Market Share by Type (2018-2033)
Figure 35. China Precision Oncology Market Share by Application (2018-2033)
Figure 36. Asia Precision Oncology Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Precision Oncology Market Share by Type (2018-2033)
Figure 38. Asia Precision Oncology Market Share by Application (2018-2033)
Figure 39. Asia Precision Oncology Market Share by Region (2018-2033)
Figure 40. Japan Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Precision Oncology Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Precision Oncology Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Precision Oncology Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Precision Oncology Market Share by Country (2018-2033)
Figure 50. Brazil Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Precision Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Acrivon Therapeutics Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 57. Bio-Serv Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 58. Exact Sciences Corporation Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 59. Illumina, Inc. Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 60. Invitae Corporation Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 61. Laboratory Corporation of America Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 62. QIAGEN Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 63. Rain Oncology Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 64. Relay Therapeutics Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 65. Strata Oncology, Inc. Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 66. Thermo Fisher Scientific Inc. Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 67. Variantyx, Inc. Revenue Growth Rate in Precision Oncology Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries